• 1
    Virelizier JL. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 1975;115:434439.
  • 2
    Virelizier JL, Oxford JS, Schild GC. The role of humoral immunity in host defence against influenza A infection in mice. Postgrad Med J 1976;52:332337.
  • 3
    Townsend AR, McMichael AJ, Carter NP, Huddleston JA, Brownlee GG. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 1984;38:1325.
  • 4
    Nguyen Hh, Van Ginkel FW, Vu HL, McGhee JR, Mestecky J. Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8 cytotoxic T lymphocytes. J Infect Dis 2001;183:368376.
  • 5
    Pyhala R, Visakorpi R, Ikonen N, Kleemola M. Influence of antigenic drift on the intensity of influenza outbreaks: Upper respiratory tract infections of military conscripts in Finland. J Med Virol 2004;72:275280.
  • 6
    Ogra PL, Chow T, Beutner KR et al. Clinical and immunological evaluation of neuraminidase-specific influenza A vaccines in humans. J Infect Dis 1977;135:499506.
  • 7
    Zebedee SL, Lamb RA. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 1988;62:27622772.
  • 8
    Zharikova D, Mozdzanowska K, Feng J, Zhang M, Gerhard W. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. J Virol 2005;79:66446654.
  • 9
    Hoshino A, Takenaka H, Mizokoshi O, Imanishi J, Kishida T, Tovey MG. Effect of anti-interferon serum of influenza virus infection in mice. Antiviral Res 1983;3:5965.
  • 10
    Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006;440:435436.
  • 11
    Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature 2005;437:889893.
  • 12
    Beigel JH, Farrar J, Han AM et al. Avian influenza A (H5 N1) infection in humans. N Engl J Med 2005;353:13741385.
  • 13
    Kong WP, Hood C, Yang ZY et al. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci U S A 2006;103:1598715991.
  • 14
    Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5 N1 Treatment? Ann Intern Med 2006;145:599609.
  • 15
    Lu J, Guo Z, Pan X et al. Passive immunotherapy for influenza A H5 N1 virus infection with equine hyperimmune globulin F(ab’ )2 in mice. Respir Res 2006;7:43.
  • 16
    Renegar KB, Small PAJ, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004;173:19781986.